Patent · US Active

Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate

US9550767B2 · kind B2 · utility

0Cited by

57References

20Claims

0Family size

Assignee

Forum Pharmaceuticals, Inc. · US

Inventors

Patricia Oliver-Shaffer · Acton, US
Gideon Shapiro · Gainesville, US
Richard Chesworth · Boston, US
Muneki Kishida · Osaka, JP
Takayuki Ishige · Osaka, JP

Key dates

Filing date	Jan 20, 2016
Grant date	Jan 24, 2017
Priority date	—
Expiry date	Jan 20, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Crystalline Forms I and II of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate and compositions, methods of manufacture and therapeutic uses thereof are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.